(Q39338371)
Statements
1 reference
The assessment of results following endocrine therapy for prostatic cancer (English)
2 references
The Assessment of Results Following Endocrine Therapy for Prostatic Cancer (English)
H. W. Baker
H. G. Burger
D. M. de Kretser
0 references
B. Hudson
G. C. Rennie
1 June 1975
1 reference
1 reference
113
1 reference
6
1 reference
824-828
1 reference
98
516
Carcinoma of the prostate: treatment comparisons (English)
1967
1
28
Carcinoma of prostate: response of plasma luteinizing hormone and testosterone to oestrogen therapy (English)
Alder
1968
2
297
Effects of synthetic oral oestrogens in normal men and patients with prostatic carcinoma: lack of gonadotrophin suppression by chlorotrianisene (English)
Baker
1973
41
235
The estimation of testosterone in biological fluids. 1 (English)
Hudson
1963
37
848
Temporal patterns of integrated plasma hormone levels during sleep and wakefulness. II. Folliclestimulating hormone, luteinising hormone, testosterone and estradiol (English)
Alford
1973
2
1037
Latency and progression in tumours: the natural history of prostatic cancer (English)
Franks
1956
83
471
Endocrine therapy in carcinoma of the prostate gland: 10-year survival studies (English)
Emmett
1960
107
450
Carcinoma of the prostate: a 15-year followup (English)
Hanash
1972
100
59
Factors in the prognosis of carcinoma of the prostate: a cooperative study (English)
1968
26
0 references
27
1012
Testosterone-binding levels in the serum of women during the normal menstrual cycle, pregnancy, and post-partum period (English)
Pearlman
1967
Identifiers
1 reference